72 More Plavix Victims Allege Drug Makers Were Aware Of Danger And File Lawsuit
At least 72 more people across the country have filed a lawsuit against the makers of the top-selling anti-blood clot drug Plavix claiming they have either suffered or been put at risk of serious bleeding episodes, strokes, heart attacks and death.
According to a report from madisonrecord.com, the 72 people who’ve suffered serious adverse reactions believe that the drug makers worked to hide evidence of the dangers of the drug. The 72 who have joined a lawsuit in the Midwest join hundreds more who have made similar claims regarding the use of Plavix.
Plavix, also called clodiprogel, is a blood thinner that prevents blood platelets from sticking together to form clots. It is a blockbuster medication, generating annual sales of over $6 billion for it’s marketers, Bristol Myers Squibb Co. and Sanofi-Aventis. In 2008, it was the world’s second-best selling drug behind Pfizer’s cholesterol drug Lipitor.
In March 2010, the FDA warned that people with the CYP2C19 variant have reduced functioning of a liver enzyme that is supposed to convert Plavix from its inactive form to its active form, potentially making Plavix ineffective at reducing the risk of blood clots. Therefore, the agency required Plavix to carry a black box warning, the strongest labeling warning the FDA can require.
To continue reading 72 More Plavix Victims Allege Drug Makers Were Aware Of Danger And File Lawsuit

